查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726216

人类乳突病毒检测市场规模、份额、趋势分析报告：按应用、产品、技术、最终用途、地区和细分市场预测，2025 年至 2030 年

Human Papilloma Virus Testing Market Size, Share, & Trends Analysis Report By Application (Cervical Cancer Screening, Vaginal Cancer Screening), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

2024 年全球人类乳突病毒 (HPV) 检测市场规模价值 17.6 亿美元，预计 2025 年至 2030 年期间的复合年增长率为 13.6%，这得益于人们对子宫颈癌和咽喉癌等 HPV 相关癌症的认识不断提高。

教育工作和公共卫生宣传活动鼓励定期检测，从而提高筛检率。

家用检测套组的普及进一步推动了市场扩张。这些套件为个人提供了一种方便、个人化且易于获取的 HPV 检测方式，使他们能够更积极地管理自己的健康。人们对家庭检测的认识不断提高以及家庭检测的普及极大地推动了市场需求。

预防性医疗保健需求的不断增长预计将推动 HPV 检测行业的发展，越来越多的人寻求早期检测以避免 HPV 相关癌症。这种向积极主动的健康实践的转变鼓励定期进行 HPV筛检，特别是对于 30 岁以上的女性。 PCR 和次世代定序等检测方法的技术进步使得 HPV 检测更加准确和有效率。这些技术创新使检测更加便利、可靠、经济高效，有助于扩大市场，改善患者的整体体验，并鼓励更广泛地采用 HPV 检测解决方案。

目录

第一章调查方法与范围

第二章执行摘要

3. 人类乳突病毒 (HPV) 检测市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人类乳突病毒（HPV）检测市场分析工具
    • 产业分析—波特五力分析
    • PESTLE分析

第四章 人类乳突病毒 (HPV) 检测市场：按应用的估计和趋势分析

  • 应用程式细分仪表板
  • 人类乳突病毒（HPV）检测市场：应用趋势分析
  • 2018-2030年全球人类乳突病毒（HPV）检测市场规模及应用趋势分析
  • 子宫颈癌筛检
  • 阴道癌筛检

第五章 人类乳突病毒 (HPV) 检测市场：产品、估值和趋势分析

  • 产品细分仪表板
  • 人类乳突病毒（HPV）检测市场：产品差异分析
  • 2018-2030年全球人类乳突病毒（HPV）检测市场规模及产品趋势分析
  • 装置
  • 耗材
  • 服务

6. 人类乳突病毒（HPV）检测市场（依技术、估值和趋势分析）

  • 技术细分仪表板
  • 人类乳突病毒（HPV）检测市场：技术变革分析
  • 2018-2030年全球人类乳突病毒（HPV）检测市场规模及趋势分析（依技术）
  • PCR
  • 免疫诊断
  • 其他的

7. 人类乳突病毒（HPV）检测市场最终用途、估值及趋势分析

  • 最终用途细分仪表板
  • 人类乳突病毒 (HPV) 检测市场：最终用途变异分析
  • 2018-2030年全球人类乳突病毒（HPV）检测市场规模及趋势分析（依最终用途）
  • 医院和诊所
  • 实验室
  • 其他的

8. 人类乳突病毒（HPV）检测市场：区域、估值和趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 区域 HPV 检测市场：关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024年主要企业热图分析
  • 公司简介
    • Abbott
    • Biomedical Diagnostics
    • bioMerieux
    • CanAg Diagnostics（Beijing）Co., Ltd.
    • Cemines
    • Bio-Rad Laboratories, Inc.
    • Epigenomics AG
    • Fujirebio
    • Guided Therapeutics, Inc.
    • Oncolab
    • Hologic, Inc.
    • Qiagen
    • Radiant Pharmaceuticals Limited
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
Product Code: GVR-4-68040-549-5

Market Size & Trends:

The global human papilloma virus testing market size was valued at USD 1.76 billion in 2024 and is expected to grow at a CAGR of 13.6% from 2025 to 2030, attributed to increasing awareness of HPV-related cancers, such as cervical and throat cancers. Educational initiatives and public health campaigns encourage people to get tested regularly, leading to higher screening rates.

The adoption of at-home testing kits is further driving market expansion. These kits provide a convenient, private, and accessible method for individuals to test for HPV, empowering users to manage their health more proactively. The combination of heightened awareness and the availability of at-home testing is significantly boosting market demand.

Rising demand for preventive healthcare is projected to fuel the growth of the HPV testing industry, with more individuals seeking early detection to avoid HPV-related cancers. This shift toward proactive health measures encourages routine HPV screenings, especially for women over 30. Technological advancements in testing methods, including PCR-based and next-generation sequencing, are further enhancing the accuracy and efficiency of HPV tests. These innovations make testing more accessible, reliable, and cost-effective, thus driving market expansion by improving the overall patient experience and encouraging broader adoption of HPV testing solutions.

Global Human Papilloma Virus Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global human papilloma virus (HPV) testing market report on the basis of application, product, technology, end use, and region:

  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Instruments
  • Consumables
  • Services
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • PCR
  • Immunodiagnostics
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Product
    • 1.2.3. Technology
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Outlook
    • 2.2.2. Product Outlook
    • 2.2.3. Technology Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Human Papilloma Virus (HPV) Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Human Papilloma Virus (HPV) Testing Market: Application Estimates & Trend Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • 4.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 4.4. Cervical Cancer Screening
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Vaginal Cancer Screening
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Papilloma Virus (HPV) Testing Market: Product Estimates & Trend Analysis

  • 5.1. Product Segment Dashboard
  • 5.2. Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • 5.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Consumables
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Services
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Papilloma Virus (HPV) Testing Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • 6.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By Technology, 2018 to 2030 (USD Million)
  • 6.4. PCR
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Immunodiagnostics
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Papilloma Virus (HPV) Testing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • 7.3. Global Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Laboratories
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Human Papilloma Virus (HPV) Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Human Papilloma Virus (HPV) Testing Market by Region: Key Takeaways
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key Country Dynamics
      • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.1.3. Competitive Scenario
      • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Germany
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.1.3. Competitive Scenario
      • 8.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. U.K.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Denmark
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Norway
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.8.3. Competitive Scenario
      • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.1.3. Competitive Scenario
      • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.4. South Korea
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.2.3. Competitive Scenario
      • 8.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.3.3. Competitive Scenario
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.4.3. Competitive Scenario
      • 8.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.5.3. Competitive Scenario
      • 8.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/ Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key Company Heat Map Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Abbott
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Biomedical Diagnostics
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. bioMerieux
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. CanAg Diagnostics (Beijing) Co., Ltd.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Cemines
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Epigenomics AG
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Fujirebio
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Guided Therapeutics, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Oncolab
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Hologic, Inc.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Qiagen
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Radiant Pharmaceuticals Limited
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. F. Hoffmann-La Roche Ltd
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Siemens Healthineers AG
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Human Papilloma Virus (HPV) Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5. Global Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 6. Global Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7. Global Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. North America Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 10. North America Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. North America Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. North America Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14. U.S. Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. U.S. Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16. U.S. Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 18. Canada Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Canada Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20. Canada Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 22. Mexico Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Mexico Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 24. Mexico Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27. Europe Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Europe Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29. Europe Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Germany Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 31. Germany Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. Germany Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33. Germany Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34. U.K. Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 35. U.K. Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 36. U.K. Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37. U.K. Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 39. France Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. France Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41. France Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 43. Italy Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Italy Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45. Italy Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 47. Spain Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48. Spain Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49. Spain Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Denmark Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 51. Denmark Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Denmark Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53. Denmark Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55. Sweden Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Sweden Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57. Sweden Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Norway Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 59. Norway Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. Norway Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 61. Norway Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68. Japan Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Japan Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70. Japan Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 72. China Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 73. China Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74. China Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 76. India Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77. India Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78. India Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79. South Korea Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 80. South Korea Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 81. South Korea Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82. South Korea Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83. Australia Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 84. Australia Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 85. Australia Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86. Australia Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Thailand Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 88. Thailand Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Thailand Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90. Thailand Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 93. Latin America Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 94. Latin America Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95. Latin America Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 97. Brazil Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 98. Brazil Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99. Brazil Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 101. Argentina Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 102. Argentina Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103. Argentina Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 110. South Africa Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 111. South Africa Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 112. South Africa Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 118. UAE Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 119. UAE Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120. UAE Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Human Papilloma Virus (HPV) Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Human Papilloma Virus (HPV) Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Human Papilloma Virus (HPV) Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Human Papilloma Virus (HPV) Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Human Papilloma Virus (HPV) Testing Market: Market Outlook
  • Fig. 10 Human Papilloma Virus (HPV) Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Human Papilloma Virus (HPV) Testing Market Driver Impact
  • Fig. 16 Human Papilloma Virus (HPV) Testing Market Restraint Impact
  • Fig. 17 Human Papilloma Virus (HPV) Testing Market Strategic Initiatives Analysis
  • Fig. 18 Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
  • Fig. 19 Human Papilloma Virus (HPV) Testing Market: Application Outlook and Key Takeaways
  • Fig. 20 Cervical Cancer Screening Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Vaginal Cancer Screening Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
  • Fig. 23 Human Papilloma Virus (HPV) Testing Market: Product Outlook and Key Takeaways
  • Fig. 24 Instruments Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Consumables Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Services Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
  • Fig. 28 Human Papilloma Virus (HPV) Testing Market: Technology Outlook and Key Takeaways
  • Fig. 29 PCR Market, 2018 - 2030 (USD Million)
  • Fig. 30 Immunodiagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market, 2018 - 2030 (USD Million)
  • Fig. 32 Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
  • Fig. 33 Human Papilloma Virus (HPV) Testing Market: End Use Outlook and Key Takeaways
  • Fig. 34 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 36 Others Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Human Papilloma Virus (HPV) Testing Market: Regional Movement Analysis
  • Fig. 38 Global Human Papilloma Virus (HPV) Testing Market: Regional Outlook and Key Takeaways
  • Fig. 39 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Kuwait Market Estimates and Forecasts, 2018 - 2030